HERON THERAPEUTICS, INC. /DE/ Unrecorded Unconditional Purchase Obligation
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Unrecorded Unconditional Purchase Obligation of $35.90 million as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Commitment and Contingencies
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount · last filed 2018-02-27
- 2017-12-31: Unrecorded Unconditional Purchase Obligation $35.90M.
- 2016-12-31: Unrecorded Unconditional Purchase Obligation $4.60M.
- 2015-12-31: Unrecorded Unconditional Purchase Obligation $3.19M.
- 2014-12-31: Unrecorded Unconditional Purchase Obligation $218.00K.
| Period end | Unrecorded Unconditional Purchase Obligation |
|---|---|
| 2017-12-31 | $35.90M 10-K · filed 2018-02-27 |
| 2016-12-31 | $4.60M 10-K · filed 2017-02-23 |
| 2015-12-31 | $3.19M 10-K · filed 2016-02-19 |
| 2014-12-31 | $218.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |